Buchumschlag

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Yunfei Wang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Statistics in Medicine
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
von: Johannes Krisam, et al.
Veröffentlicht: (2024)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
von: Tianyu Zhan
Veröffentlicht: (2024)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
von: Jialu Fang, et al.
Veröffentlicht: (2024)

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
von: Wenhao Cao, et al.
Veröffentlicht: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
von: Amin Yarahmadi, et al.
Veröffentlicht: (2024)

Assurance methods for designing a clinical trial with a delayed treatment effect
von: James A. Salsbury, et al.
Veröffentlicht: (2024)

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
von: Peiran Liu, et al.
Veröffentlicht: (2024)

Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization
von: Peng Yang, et al.
Veröffentlicht: (2024)

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
von: Luana Boumendil, et al.
Veröffentlicht: (2024)

Statistical considerations in model‐based dose finding for binary responses under model uncertainty
von: Zhiwu Yan, et al.
Veröffentlicht: (2024)

Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
von: Xiaosong Shi, et al.
Veröffentlicht: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
von: Shuxi Zeng, et al.
Veröffentlicht: (2024)

Correction to “Using principal stratification in analysis of clinical trials”
von: Ilya Lipkovich, et al.
Veröffentlicht: (2024)

Use of win time for ordered composite endpoints in clinical trials
von: James F. Troendle, et al.
Veröffentlicht: (2024)

Confidence distributions for treatment effects in clinical trials: Posteriors without priors
von: Ian C. Marschner
Veröffentlicht: (2024)

A sequential, multiple assignment, randomized trial design with a tailoring function
von: Holly Hartman, et al.
Veröffentlicht: (2024)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
von: Jonathan C. Moyer, et al.
Veröffentlicht: (2024)

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
von: Yu Du, et al.
Veröffentlicht: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
von: Stephen Schüürhuis, et al.
Veröffentlicht: (2024)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
von: Gi‐Ming Wang, et al.
Veröffentlicht: (2026)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
von: Matthias Kormaksson, et al.
Veröffentlicht: (2024)

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
von: Edward L. Korn, et al.
Veröffentlicht: (2024)

Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
von: Rebecca B. Silva, et al.
Veröffentlicht: (2024)

Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa
von: Jaehyun Seo, et al.
Veröffentlicht: (2024)

Accounting for Carryover Toxicity in Phase I Clinical Trials with Intra‐Patient Dose Escalation
von: Chloe E. Falke, et al.
Veröffentlicht: (2025)

Beyond the two‐trials rule
von: Leonhard Held
Veröffentlicht: (2024)

Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
von: Dustin J. Rabideau, et al.
Veröffentlicht: (2024)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I– II Oncology Dose Finding Trials
von: Andrew Hall, et al.
Veröffentlicht: (2026)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
von: Yichen Yan, et al.
Veröffentlicht: (2025)

REDOMA: Bayesian random‐effects dose‐optimization meta‐analysis using spike‐and‐slab priors
von: Cheng‐Han Yang, et al.
Veröffentlicht: (2024)

Robust analysis of stepped wedge trials using composite likelihood models
von: Emily C. Voldal, et al.
Veröffentlicht: (2024)

Modeling intra‐individual inter‐trial EEG response variability in autism
von: Mingfei Dong, et al.
Veröffentlicht: (2024)

Determining sample size in a personalized randomized controlled (PRACTical) trial
von: Rebecca M. Turner, et al.
Veröffentlicht: (2024)

Approximate balancing weights for clustered observational study designs
von: Eli Ben‐Michael, et al.
Veröffentlicht: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
von: Carly Lupton Brantner, et al.
Veröffentlicht: (2024)

Confidence intervals for odds ratio from multistage randomized phase II trials
von: Shiwei Cao, et al.
Veröffentlicht: (2024)

Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
von: Thomas Burnett, et al.
Veröffentlicht: (2024)

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
von: Samuel K Sarkodie, et al.
Veröffentlicht: (2024)

Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers
von: Yanping Chen, et al.
Veröffentlicht: (2024)

A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study
von: Zoë S. Dunias, et al.
Veröffentlicht: (2024)